%0 Journal Article
%T Trastuzumab and pertuzumab in circulating tumor DNA ERBB2-amplified HER2-positive refractory cholangiocarcinoma
%A Ashton Ritter
%A Bhavya Yarlagadda
%A Faisal Shahjehan
%A Pashtoon M. Kasi
%A Vaishnavi Kamatham
%J Archive of "NPJ Precision Oncology".
%D 2019
%R 10.1038/s41698-019-0091-4
%K Targeted therapies
%K Biliary tract cancer
%K Cancer genetics
%K Tumour heterogeneity
%K Tumour biomarkers
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6700112/